METTL7B-stabilized lncRNA-MIR22HG to drive p53-mediated neuronal apoptosis via the ubiquitinating JARID2 in cerebral ischemia/reperfusion injury
Open Access
- 5 February 2026
- journal article
- research article
- Published by Springer Nature in Cell Biology and Toxicology
- Vol. 42 (1)
Abstract
Ischemic stroke (IS) constitutes a leading driver of mortality and morbidity worldwide, with neuronal apoptosis representing a key pathological process. Accordingly, our objective was to delve into the implications of a novel signaling axis of the m6A methyltransferase METTL7B, lncRNA-MIR22HG, and JARID2 in driving neuronal apoptosis throughout cerebral ischemia/reperfusion (I/R) injury (CIRI). Mice subjected to middle cerebral artery occlusion/reperfusion (MCAO/R) and N2a cells exposed to oxygen–glucose deprivation/reoxygenation (OGD/R) were, respectively, established as in vivo and in vitro I/R models. METTL7B was markedly up-regulated after I/R and enhanced the m6A methylation and stability of lncRNA-MIR22HG, significantly prolonging its transcript half-life and amplifying its biological effects on neuronal fate. Stabilized lncRNA-MIR22HG suppressed the ubiquitin-mediated degradation of JARID2, thereby increasing JARID2 abundance and activity. Elevated JARID2 promoted the assembly of the p53/p300/MDM2 transcriptional complex, which in turn up-regulated the levels of pro-apoptotic genes, ultimately exacerbating neuronal apoptosis alongside ischemic brain injury. Functionally, METTL7B overexpression aggravated neurological deficits, infarct volume, and neuronal apoptosis in vivo, whereas METTL7B knockdown alleviated ischemic damage and conferred robust neuroprotection. Collectively, these findings define a novel METTL7B/lncRNA-MIR22HG/JARID2 signaling axis that integrates RNA methylation, lncRNA stabilization, proteostasis, and transcriptional activation of apoptosis, and highlight METTL7B as a potential novel target for therapeutic strategies aimed at preventing and treating ischemic stroke. Graphical Abstract Schematic illustration of the METTL7B/lncRNA-MIR22HG/JARID2 signaling axis during cerebral ischemia/reperfusion injury. Ischemic stress up-regulates METTL7B, which enhances m6A methylation and stabilizes MIR22HG. Stabilized lncRNA-MIR22HG prevents ubiquitin-mediated degradation of JARID2, promoting its accumulation. Elevated JARID2 facilitates the assembly of the p53/p300/MDM2 transcriptional complex, leading to transcriptional activation of pro-apoptotic genes (Bax, Puma, Noxa) and aggravation of neuronal apoptosis during I/R injury. 1. METTL7B stabilizes lncRNA-MIR22HG, enhancing neuronal apoptosis in cerebral ischemia/reperfusion injury. 2. MIR22HG prevents the ubiquitin-mediated degradation of JARID2, promoting the p53/p300/MDM2 complex. 3. METTL7B upregulation exacerbates infarct volume, neuronal apoptosis, and neurological deficits. 4. Knockdown of METTL7B offers neuroprotection, highlighting it as a potential therapeutic target.Keywords
Funding Information
- National Natural Science Foundation of China (82301476)
- Natural Science Foundation of Guangdong Province (2021A1515011064)
This publication has 58 references indexed in Scilit:
- m6A-Induced lncRNA MEG3 Promotes Cerebral Ischemia-Reperfusion Injury Via Modulating Oxidative Stress and Mitochondrial Dysfunction by hnRNPA1/Sirt2 AxisMolecular Neurobiology, 2024
- METTL3-deficiency Suppresses Neural Apoptosis to Induce Protective Effects in Cerebral I/R Injury via Inhibiting RNA m6A Modifications: A Pre-clinical and Pilot StudyNeurochemical Research, 2023
- METTL7B contributes to the malignant progression of glioblastoma by inhibiting EGR1 expressionMetabolic Brain Disease, 2022
- Ischemic StrokeThe American Journal of Medicine, 2021
- Long Non-coding RNA PVT1 Inhibits miR-30c-5p to Upregulate Rock2 to Modulate Cerebral Ischemia/Reperfusion Injury Through MAPK Signaling Pathway ActivationMolecular Neurobiology, 2021
- Construction of lncRNA-Mediated ceRNA Network for Investigating Immune Pathogenesis of Ischemic StrokeMolecular Neurobiology, 2021
- The role of P53 up-regulated modulator of apoptosis (PUMA) in ovarian development, cardiovascular and neurodegenerative diseasesApoptosis, 2021
- Diagnosis and Management of Transient Ischemic Attack and Acute Ischemic StrokeJAMA, 2021
- Long non-coding RNA GAS5, by up-regulating PRC2 and targeting the promoter methylation of miR-424, suppresses multiple malignant phenotypes of gliomaJournal of Neuro-Oncology, 2020
- Silencing of Long Non-coding RNA GAS5 Suppresses Neuron Cell Apoptosis and Nerve Injury in Ischemic Stroke Through Inhibiting DNMT3B-Dependent MAP4K4 MethylationTranslational Stroke Research, 2020